Efficacy and drawbacks of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the thoracic esophagus

Hepato-Gastroenterology

Volumn 58, Issue 109, 2011, Pages 1214-1219

  Wolfárd, Antal ^a   Paszt, Attila ^a   Szentpáli, Károly ^a   Hideghéthy, Katalin ^b   Uhercsák, Gabriella ^b   Németh, István ^b   Tiszlavicz, László ^b   Lázár, György ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Esophageal cancer; Neoadjuvant chemoradiotherapy; Oncogene expression; Postoperative complications

Indexed keywords

CARBOPLATIN; FLUOROURACIL; KI 67 ANTIGEN; PROTEIN P21; PROTEIN P53;

ADULT; ANASTOMOSIS LEAKAGE; ARTICLE; BONE MARROW TOXICITY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; ESOPHAGOGASTROSTOMY; ESOPHAGUS RESECTION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG INFECTION; LUNG METASTASIS; LUNG TOXICITY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; STENT; SURGICAL MORTALITY; TREATMENT RESPONSE; TUMOR BIOPSY; WEIGHT REDUCTION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; GASTROSTOMY; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 83355165064     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge09500     Document Type: Article

References (18)

1. Gallo A, Cha C: Updates on esophageal and gastric cancers. World J Gastroenterol 2006; 12(20):3237-3242. (Pubitemid 43881349)
2. Chong G, Cunningham D: Gastrointestinal cancer: recent developments in medical oncology. Eur J Surg Oncol 2005; 31(5):453-460. (Pubitemid 40724083)
3. Robb WB, Naughton P, Walsh TN: Neoadjuvant treatment of oesophageal adenocarcinoma. Minerva Chir 2004; 59(5):461-470. (Pubitemid 39490653)
4. Geh JI, Bond SJ, Bentzen SM, Glynne-Jones R: Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiother Oncol 2006; 78(3):236-244
5. Wright CD: Esophageal cancer surgery in 2005. Minerva Chir 2005; 60(6):431-444.
6. Shivnani AT, Small W Jr, Stryker SJ, Kiel KD, Lim S, Halverson AL, Talamonti MS: Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors. Am J Surg 2007; 193(3):389-393.
7. Greer SE, Goodney PP, Sutton JE, Birkmeyer JD: Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery 2005; 137:172-177. (Pubitemid 40174424)
8. Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, Ackland S, Gotley DC, Joseph D, Millar J, North J, Walpole ET, Denham JW: Trans-Tasman Radiation Oncology Group; Australian Gastro-Intestinal Trials Group: Surgery alone versus chemoradiotherapy followed by surgery for respectable cancer of the esophagus: a randomized controlled phase III trial. Lancet Oncol 2005; 6(9):659-668. (Pubitemid 41222756)
9. Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Franke C, Wilke H: Chemoradiationn with and without surgery in patients with locally advanced squamous cell carcinoma in the esophagus. J Clin Oncol 2005; 23(10):2310-2317 (Pubitemid 46218723)
10. Berger AC, Farma J, Scott WJ, Freedmann G, Weiner L, Cheng JD, Wang H, Goldberg M: Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 2005; 23(19):4330-4337. (Pubitemid 46207006)
11. Fujiwara Y, Kamikonya N, Inoue T, Koishi K, Yoshikawa R, Nakao K, Yagyu R, Nishiwaki M, Fujiwara M, Kojima S, Nakagawa K, Yamamura T: Chemoradiotherapy for T3 and T4 squamous cell carcinoma of the esophagus using low-dose FP and radiation: a preliminary report. Oncol Rep 2005; 14(5):1177-1182
12. Zhang X, Watson DI, Jamieson GG, Bessell JR, Devitt PG: Neoadjuvant chemoradiotherapy for esophageal carcinoma. Dis Esophagus 2005; 18(2):104-108. (Pubitemid 40975422)
13. Mitchell JD: Anastomotic leak after esophagectomy. Thorac Surg Clin 2006; 16(1):1-9
14. Blewett CJ, Miller JD, Young JE, Bennett WF, Urschel JD: Anastomotic leaks after esophagectomy for esophageal cancer: a comparison of thoracic and cervical anastomoses. Ann Thorac Cardiovasc Surg 2001; 7(2):75-78.
15. Junemann-Ramirez M, Awan MY, Khan ZM, Rahamim JS: Anastomotic leakage post-esophagogastrectomy for esophageal carcinoma: retrospective analysis of predictive factors, management and influence on long-term survival in a high volume centre. Eur J Cardiothorac Surg 2005; 27(1):3-7. (Pubitemid 40038519)
16. Kelley ST, Coppola D, Karl RC: Neoadjuvant chemoradiotherapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy. J Gastrointest Surg 2004; 8(3):227-231
17. Walsh TN, Grannell M, Mansoor S: Predictive factors for success of neo-adjuvant therapy in upper gastrointestinal cancer. J Gastroenterol Hepatol 2002; 17:S172-175. (Pubitemid 34539306)
18. Kitamura K, Saeki H, Kawaguchi H, Araki K, Ohno S, Kuwano H, Maehara Y, Sugimachi K: Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer. Hepatogastroenterology 2000; 47(32):419-423. (Pubitemid 30216304)